Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

Share Price is delayed by 15 minutes
Get Live Data
2.435    -0.005 (-0.20%)
Bid:
2.43
Ask:
2.44
Spread: 0.01 (0.412%)
Market Cap: $8.03b
CBKD Live PriceLast checked at - London Stock Exchange

Intraday Com.int.bk.regs Share Chart

  • This share is an international stock.

CIB 1st Quarter Separate Results

5 May 2020 07:00

RNS Number : 8643L
Commercial Intnl Bank (Egypt) SAE
05 May 2020
Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Commercial International Bank (Egypt) S.A.E.

Separate Financial Statements

March 31, 2020

Ā 

Ā 

Ā 

Ā 

Ā 

Click on, or paste the following link into your web browser, to view the associated PDF document.

Ā 

http://www.rns-pdf.londonstockexchange.com/rns/8643L_1-2020-5-4.pdf

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Separate balance sheet as at March 31, 2020

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Notes

Ā 

Ā 

Mar. 31, 2020

Ā 

Ā 

Ā 

Dec. 31, 2019

Ā 

Ā 

Ā 

Ā 

EGP Thousands

Ā 

Ā 

Ā 

EGP Thousands

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Assets

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Cash and balances with central bank

15

Ā 

Ā 

Ā 27,169,495

Ā 

Ā 

Ā 

Ā 28,273,962

Due from banks

16

Ā 

Ā 

Ā 26,608,406

Ā 

Ā 

Ā 

Ā 28,353,366

Loans and advances to banks, net

18

Ā 

Ā 

Ā 937,043

Ā 

Ā 

Ā 

Ā 625,264

Loans and advances to customers, net

19

Ā 

Ā 

Ā 115,422,951

Ā 

Ā 

Ā 

Ā 119,321,103

Derivative financial instruments

20

Ā 

Ā 

Ā 377,344

Ā 

Ā 

Ā 

Ā 216,383

Investments

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

- Financial Assets at Fair Value through P&L

21

Ā 

Ā 

Ā 314,665

Ā 

Ā 

Ā 

Ā 418,781

- Financial Assets at Fair value through OCI

21

Ā 

Ā 

Ā 92,469,884

Ā 

Ā 

Ā 

89,897,257

-Amortized cost

21

Ā 

Ā 

Ā 106,531,563

Ā 

Ā 

Ā 

107,225,613

-Investments in associates and subsidiaries

22

Ā 

Ā 

49,132

Ā 

Ā 

Ā 

63,953

Other assets

23

Ā 

Ā 

9,011,803

Ā 

Ā 

Ā 

Ā 9,747,939

Deferred tax assets (Liabilities)

31

Ā 

Ā 

425,580

Ā 

Ā 

Ā 

Ā 350,339

Property, plant and equipment

24

Ā 

Ā 

Ā 2,226,095

Ā 

Ā 

Ā 

Ā 2,202,698

Total assets

Ā 

Ā 

Ā 

381,543,775

Ā 

Ā 

Ā 

Ā 386,696,658

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Liabilities and equity

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Liabilities

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Due to banks

25

Ā 

Ā 

Ā 10,437,923

Ā 

Ā 

Ā 

Ā 11,810,607

Due to customers

26

Ā 

Ā 

Ā 309,997,120

Ā 

Ā 

Ā 

Ā 304,483,655

Derivative financial instruments

20

Ā 

Ā 

Ā 479,441

Ā 

Ā 

Ā 

Ā 282,588

Current tax liabilities

Ā 

Ā 

Ā 

Ā 1,332,487

Ā 

Ā 

Ā 

Ā 4,639,364

Other liabilities

28

Ā 

Ā 

Ā 7,674,064

Ā 

Ā 

Ā 

Ā 8,396,487

Other loans

27

Ā 

Ā 

Ā 3,181,170

Ā 

Ā 

Ā 

Ā 3,272,746

Provisions

29

Ā 

Ā 

Ā 2,389,204

Ā 

Ā 

Ā 

Ā 2,011,369

Total liabilities

Ā 

Ā 

Ā 

Ā 335,491,409

Ā 

Ā 

Ā 

Ā 334,896,816

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Equity

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Issued and paid up capital

30

Ā 

Ā 

Ā 14,690,821

Ā 

Ā 

Ā 

14,690,821

Reserves

33

Ā 

Ā 

Ā 27,862,114

Ā 

Ā 

Ā 

24,342,314

Reserve for employee stock ownership plan (ESOP)

33

Ā 

Ā 

Ā 1,108,221

Ā 

Ā 

Ā 

963,152

Retained earnings *

33

Ā 

Ā 

Ā 2,391,210

Ā 

Ā 

Ā 

11,803,555

Total equity

Ā 

Ā 

Ā 

Ā 46,052,366

Ā 

Ā 

Ā 

51,799,842

Total liabilities and equity

Ā 

Ā 

Ā 

Ā 381,543,775

Ā 

Ā 

Ā 

386,696,658

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

The accompanying notes are an integral part of these financial statements.

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

(Review report attached)

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

*Including net profit for the current period

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Hisham Ezz Al-Arab

Ā 

Ā 

Ā 

Ā 

Chairman and Managing Director

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Separate income statement for the period ended March 31, 2020

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Note

Mar. 31, 2020

Ā 

Ā 

Mar. 31, 2019

Ā 

Ā 

Ā 

EGP Thousands

Ā 

Ā 

EGP Thousands

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Interest and similar income

Ā 

Ā 

Ā 10,687,101

Ā 

Ā 

Ā 10,278,050

Interest and similar expense

Ā 

Ā 

Ā (4,491,834)

Ā 

Ā 

Ā (5,339,464)

Net interest income

Ā 

6

Ā 6,195,267

Ā 

Ā 

Ā 4,938,586

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Fee and commission income

Ā 

Ā 

Ā 805,413

Ā 

Ā 

Ā 855,477

Fee and commission expense

Ā 

Ā 

Ā (305,561)

Ā 

Ā 

Ā (277,625)

Net fee and commission income

Ā 

7

Ā 499,852

Ā 

Ā 

Ā 577,852

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Dividend income

Ā 

8

-

Ā 

Ā 

121

Net trading income

Ā 

9

(5,425)

Ā 

Ā 

249,879

Profits (Losses) on financial investments

Ā 

21

470,150

Ā 

Ā 

6,377

Administrative expenses

Ā 

10

(1,524,538)

Ā 

Ā 

(1,320,672)

Other operating (expenses) income

Ā 

11

(747,740)

Ā 

Ā 

(141,097)

Intangible assets amortization

Ā 

Ā 

-

Ā 

Ā 

(32,552)

Impairment release (charges) for credit losses

Ā 

12

(1,240,110)

Ā 

Ā 

(520,727)

Ā 

Profit before income tax

Ā 

Ā 

Ā 

3,648,456

Ā 

Ā 

Ā 

3,757,767

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Income tax expense

Ā 

13

(1,332,487)

Ā 

Ā 

(1,090,009)

Deferred tax assets (Liabilities)

Ā 

31 - 13

75,241

Ā 

Ā 

(25,411)

Net profit for the period

Ā 

Ā 

2,391,210

Ā 

Ā 

2,642,347

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Earnings per share

Ā 

14

1.44

Ā 

Ā 

1.59

Basic

Ā 

Ā 

1.43

Ā 

Ā 

1.58

Diluted

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Hisham Ezz Al-Arab

Ā 

Ā 

Ā 

Ā 

Ā 

Chairman and Managing Director

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā Ā Ā Ā Ā Ā Ā Ā Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Separate statement of other comprehensive income for the period ended March 31, 2020

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Notes

Mar. 31, 2020

Ā 

Mar. 31, 2019

Ā 

EGP Thousands

Ā 

EGP Thousands

Ā 

Ā 

Ā 

Ā 

Ā 

Net profit for the period

Ā 

2,391,210

Ā 

Ā 

2,642,347

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Net change in fair value of debt instruments measured at fair value through other comprehensive income

Ā 

(4,865,970)

Ā 

Ā 

2,442,704

Ā 

Net change in fair value of debt instruments measured at fair value through other comprehensive income

Ā 

(47,321)

Ā 

Ā 

(107,122)

Ā 

Expected credit loss for fair value of debt instruments measured at fair value through other comprehensive income

Ā 

Ā 

Ā 

Ā 

Total other comprehensive income for the year

Ā 

(2,522,081)

Ā 

4,977,929

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Separate cash flow for the period ended March 31, 2020

Ā 

Notes

Mar. 31, 2020

Ā 

Mar. 31, 2019

Ā 

Ā 

EGP Thousands

Ā 

EGP Thousands

Ā 

Ā 

Ā 

Ā 

Ā 

Cash flow from operating activities

Ā 

Ā 

Ā 

Ā 

Profit before income tax

Ā 

3,648,456

Ā 

Ā 

3,757,767

Ā 

Adjustments to reconcile net profit to net cash provided by operating activities

Ā 

Ā 

Ā 

Ā 

Fixed assets depreciation

24

160,538

Ā 

131,898

Impairment charge for credit losses (Loans and advances to customers)

12

1,272,649

Ā 

634,951

Other provisions charges

29

439,410

Ā 

2,077

Impairment charge for credit losses (due from banks)

12

14,782

Ā 

(7,102)

Impairment charge for credit losses (financial investments)

12

(47,321)

Ā 

(107,122)

Impairment charge for other assets

23

13,707

Ā 

24,814

Exchange revaluation differences for financial assets at fair value through OCI

21

287,889

Ā 

334,394

Intangible assets amortization

Ā 

-

Ā 

32,552

Impairment charge financial assets at fair value through OCI

21

-

Ā 

45,664

Exchange differences in financial investments in subsidiary

22

719

Ā 

1,485

Utilization of other provisions

29

(726)

Ā 

2,461

Other provisions no longer used

29

(38,630)

Ā 

(164,335)

Exchange differences of other provisions

29

(22,219)

Ā 

(37,871)

(Profits) losses from selling property, plant and equipment

11

(94)

Ā 

-

(Profits) losses from selling financial investments

21

(554,113)

Ā 

(52,041)

Shares based payments

Ā 

145,069

Ā 

124,000

Released (Impairment) charges of investments in associates and subsidiaries

Ā 

Ā 

Ā 

Ā 

14,100

Ā 

-

Released (Impairment) charges of equity instruments

Ā 

69,863

Ā 

-

Operating profits before changes in operating assets and liabilities

Ā 

Ā 

5,404,079

Ā 

4,723,592

Ā 

Ā 

Ā 

Ā 

Ā 

Net decrease (increase) in assets and liabilities

Ā 

Ā 

Ā 

Ā 

Due from banks

15

211,025

Ā 

(17,549,341)

Treasury bills and other governmental notes

Ā 

-

Ā 

15,781,350

Financial assets at fair value through P&L

21

104,116

Ā 

2,180,287

Derivative financial instruments

20

35,892

Ā 

(47,159)

Loans and advances to banks and customers

18 - 19

2,428,551

Ā 

(6,035,057)

Other assets

40

857,769

Ā 

(587,120)

Due to banks

25

(1,372,684)

Ā 

(3,921,303)

Due to customers

26

5,513,465

Ā 

8,051,449

Income tax obligations paid

Ā 

(4,639,364)

Ā 

(3,762,070)

Other liabilities

28

(722,423)

Ā 

3,487,750

Net cash provided from operating activities

Ā 

7,820,426

Ā 

2,322,378

Ā 

Ā 

Ā 

Ā 

Ā 

Cash flow from investing activities

Ā 

Ā 

Ā 

Ā 

Payment for purchases of property, plant, equipment and branches constructions

Ā 

(319,089)

Ā 

(483,048)

Proceeds from selling property, plant and equipment

11

94

Ā 

-

Proceeds from redemption of financial assets at amortized cost

21

45,639,889

Ā 

33,452,378

Payment for purchases of financial assets at amortized cost

21

(44,945,839)

Ā 

(32,834,360)

Payment for purchases of financial assets at fair value through OCI

21

(62,050,349)

Ā 

(4,493,603)

Proceeds from selling financial assets at fair value through OCI

Ā 

54,866,521

Ā 

4,617,766

Net cash used in investing activities

Ā 

(6,808,773)

Ā 

259,133

Ā 

Ā 

Ā 

Ā 

Ā 

Cash flow from financing activities

Ā 

Ā 

Increase (decrease) in long term loans

27

(91,576)

(114,541)

Dividend paid

Ā 

(3,370,464)

(2,700,544)

Net cash used in (provided from) financing activities

Ā 

(3,462,040)

(2,815,085)

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Net increase (decrease) in cash and cash equivalent during the year

Ā 

(2,450,387)

(233,574)

Beginning balance of cash and cash equivalent

Ā 

22,895,017

34,303,645

Cash and cash equivalent at the end of the year

Ā 

20,444,630

34,070,071

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Cash and cash equivalent comprise:

Ā 

Ā 

Cash and balances with central bank

15

27,169,495

24,741,584

Due from banks

16

26,640,005

51,538,237

Treasury bills and other governmental notes

17

29,091,960

33,831,714

Obligatory reserve balance with CBE

15

(22,186,285)

(17,837,693)

Due from banks with maturities more than three months

Ā 

(10,415,104)

(23,971,797)

Treasury bills with maturity more than three months

Ā 

(29,855,441)

(34,231,974)

Total cash and cash equivalent

Ā 

20,444,630

34,070,071

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Separate statement of changes in shareholders' equity for the year ended March 31, 2019

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Mar. 31, 2019

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

EGP Thousands

Beginning balance

11,668,326

1,710,293

12,776,215

1,549,445

12,421

(1,860,851)

4,323

9,555,755

738,320

36,154,247

Capital increase

2,917,082

-

(2,917,082)

-

-

-

-

-

-

-

Transferred to reserves

-

477,736

6,375,589

-

1,045

-

-

(6,854,370)

-

-

Dividend paid

-

-

-

-

-

-

-

(2,700,544)

-

(2,700,544)

Net profit for the period

-

-

-

-

-

-

-

2,642,347

-

2,642,347

Net unrealised gain/(loss) on financial assets at fair value through OCI

-

-

-

-

-

2,442,704

-

-

-

2,442,704

Transferred (from) to bank risk reserve

-

-

-

-

-

-

841

(841)

-

-

ECL for impairment of debt instruments investments

-

-

-

-

-

(107,122)

-

-

-

(107,122)

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

124,000

124,000

Ending balance

14,585,408

2,188,029

16,234,722

1,549,445

13,466

474,731

5,164

2,642,347

862,320

38,555,632

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Separate statement of changes in shareholders' equity for the year ended March 31, 2020

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Mar. 31, 2020

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

EGP Thousands

Beginning balance

14,690,821

2,188,029

16,474,429

1,549,445

13,466

4,111,781

5,164

11,803,555

963,152

51,799,842

Capital increase

-

-

-

-

-

-

-

-

-

-

Transferred to reserves

-

590,106

7,840,286

-

1,440

-

-

(8,431,832)

-

-

Dividend paid

-

-

-

-

-

-

-

(3,370,464)

-

(3,370,464)

Net profit for the period

-

-

-

-

-

-

-

2,391,210

-

2,391,210

Net unrealised gain/(loss) on financial assets at fair value through OCI

-

-

-

-

-

(4,865,970)

-

-

-

(4,865,970)

Transferred (from) to bank risk reserve

-

-

-

-

-

-

1,259

(1,259)

-

-

Release provision for impairment of debt instruments investments

-

-

-

Ā 

-

(47,321)

-

-

-

(47,321)

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

145,069

145,069

Ending balance

14,690,821

2,778,135

24,314,715

1,549,445

14,906

(801,510)

6,423

2,391,210

1,108,221

46,052,366

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā Ā Ā Ā Ā Ā Ā Ā Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Ā 
END
Ā 
Ā 
QRFUSRVRRWUVRAR
Date   Source Headline
12th May 202610:18 amRNS1st Quarter Results
12th May 202610:16 amRNSCIB Consolidated Financial Statements 1Q26
12th May 202610:15 amRNS1Q26 Earnings Release
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
24th Feb 202612:31 pmRNSItems of Extraordinary GA
24th Feb 20267:00 amRNSPress Release dated 23th February 2026
19th Feb 20261:20 pmRNSItems of Extraordinary GA
19th Feb 20261:17 pmRNSInvitation to the Extraordinary GA 2026
19th Feb 20268:00 amRNSItems of OGA 2026
19th Feb 20268:00 amRNSInvitation to the OGA March 15
10th Feb 20267:00 amRNSCIB Summary of Board Resolution 9 Feb 2026
10th Feb 20267:00 amRNSFY25 Earnings Release
10th Feb 20267:00 amRNSCIB IFRS Consolidated Financial Statements FY25
15th Dec 20257:00 amRNSChange in Board of Directors
3rd Dec 20254:35 pmRNSCIB Bonus Shares Distribution 2025
4th Nov 20257:00 amRNSCIB Condensed Consolidated 3rd Quarter Results
4th Nov 20257:00 amRNSCIB 9M25 Earnings Release
4th Nov 20257:00 amRNS3rd Quarter Results
25th Sep 20253:55 pmRNSSummary of Resolutions - GAM September 2025
1st Sep 20257:02 amRNSInvitation to General Assembly September 2025
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Consolidated Financials
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Separate Financials
22nd Jul 20257:00 amRNS2Q25 Earnings Release
28th May 20256:00 pmRNSChanges to the Board of Directors
13th May 20257:00 amRNSSeparate- Q12025
13th May 20257:00 amRNS1Q25 Press Release
13th May 20257:00 amRNSConsolidated Financial Position at March 31.2025
24th Mar 20257:00 amRNSOrdinary General Assembly Resolutions Summary 2025
28th Feb 20257:00 amRNSGeneral Assembly 2025 - Discussion Items - amended
27th Feb 20257:47 amRNSInvitation to General Assembly 2025
27th Feb 20257:15 amRNSGeneral Assembly 2025 - Discussion Items
19th Feb 20257:00 amRNSCIB Annual Financial Report
19th Feb 20257:00 amRNSCIB FY2024 Earnings Release
6th Nov 20247:58 amRNSCIB gets regulatory approvals to changes to BoD
4th Nov 20247:00 amRNSEarnings Release 3Q.2024
4th Nov 20247:00 amRNSCIB-Separate Financial Statements 3Q.2024
4th Nov 20247:00 amRNSCIB-Consolidated Financial Statements 3Q.2024
1st Oct 20242:00 pmRNSCIB obtaining Long term loan from IFC
16th Sep 20248:00 amRNSChanges in CIB's Board of Directors
22nd Jul 20247:00 amRNSH1.2024 Press Release
22nd Jul 20247:00 amRNSCIB H1-2024 Separate Financial Statements - E
22nd Jul 20247:00 amRNSCIB H1-2024 Consolidated Financial Statements
13th May 20247:00 amRNS1st Quarter Results - Consolidated Statements
13th May 20247:00 amRNS1st Quarter Results - Separate Statements
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.